FDA Inspection 1053982 — Rozalia Olsavszky
The FDA completed an inspection of Rozalia Olsavszky on Apr 5, 2018 in Bucharest. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 5, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bucharest (Romania)
Additional Details
Clinical Investigator (CI)